Marapharm Ventures Inc Stock Canadian Securities Exchange
Equities
CA56575M1086
Healthcare Facilities & Services
Sales 2020 | 2.27 3.09 | Sales 2021 | 3.15 4.29 | Capitalization | 10.06M 13.7M |
---|---|---|---|---|---|
Net income 2020 | -40M -54.5M | Net income 2021 | -8M -10.9M | EV / Sales 2020 | 13,592,488 x |
Net Debt 2020 | 5.3M 7.22M | Net Debt 2021 | 13.31M 18.13M | EV / Sales 2021 | 7,417,546 x |
P/E ratio 2020 |
-0.45
x | P/E ratio 2021 |
-1.08
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 71.26% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Searle
IRO | Public Communications Contact | - | - |
James O’Sullivan
SEC | Corporate Secretary | - | 20-11-17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Scott R. Berman
BRD | Director/Board Member | - | - |
Dylan Rexing
BRD | Director/Board Member | - | 20-10-07 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 339M | |
+24.69% | 239M | |
+10.31% | 224M | |
+36.05% | 178M | |
+141.20% | 137M | |
-28.57% | 121M | |
+32.61% | 119M | |
-47.02% | 113M | |
-.--% | 87.08M |